CN111904996A - Bone spur repairing cream containing Hetian jade microelements - Google Patents
Bone spur repairing cream containing Hetian jade microelements Download PDFInfo
- Publication number
- CN111904996A CN111904996A CN202010701310.1A CN202010701310A CN111904996A CN 111904996 A CN111904996 A CN 111904996A CN 202010701310 A CN202010701310 A CN 202010701310A CN 111904996 A CN111904996 A CN 111904996A
- Authority
- CN
- China
- Prior art keywords
- hetian jade
- powder
- jade
- hetian
- cream containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000010977 jade Substances 0.000 title claims abstract description 33
- 239000006071 cream Substances 0.000 title claims abstract description 17
- 208000008558 Osteophyte Diseases 0.000 title claims abstract description 16
- 201000010934 exostosis Diseases 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 16
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 3
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims abstract description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 3
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 3
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 3
- 229960001631 carbomer Drugs 0.000 claims abstract description 3
- 229940081733 cetearyl alcohol Drugs 0.000 claims abstract description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 3
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 3
- 229940057910 shea butter Drugs 0.000 claims abstract description 3
- 239000008117 stearic acid Substances 0.000 claims abstract description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000011925 Passiflora alata Nutrition 0.000 claims description 6
- 235000000370 Passiflora edulis Nutrition 0.000 claims description 6
- 235000011922 Passiflora incarnata Nutrition 0.000 claims description 6
- 235000013750 Passiflora mixta Nutrition 0.000 claims description 6
- 235000013731 Passiflora van volxemii Nutrition 0.000 claims description 6
- 244000273928 Zingiber officinale Species 0.000 claims description 6
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 6
- 235000008397 ginger Nutrition 0.000 claims description 6
- 239000011573 trace mineral Substances 0.000 claims description 6
- 235000013619 trace mineral Nutrition 0.000 claims description 6
- 240000002690 Passiflora mixta Species 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 244000241257 Cucumis melo Species 0.000 claims description 4
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 241000238565 lobster Species 0.000 claims description 3
- 235000015067 sauces Nutrition 0.000 claims description 3
- 241001116742 Drynaria Species 0.000 claims description 2
- 241001608711 Melo Species 0.000 claims description 2
- 229910052785 arsenic Inorganic materials 0.000 claims description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 2
- 229910052753 mercury Inorganic materials 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 9
- 210000000988 bone and bone Anatomy 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000008439 repair process Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000002435 tendon Anatomy 0.000 abstract description 6
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 229940075529 glyceryl stearate Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000353135 Psenopsis anomala Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001254604 Angelica pubescens Species 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000701408 Euphorbia kansui Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 235000015912 Impatiens biflora Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000008440 Passiflora incarnata Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000304460 Sinocrassula yunnanensis Species 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000917 skin toxin Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a Hetian jade microelement bone spur repairing cream which comprises the following components in percentage by mass: 4-20% of traditional Chinese medicine composition, 1-10% of ultramicro Hetian jade powder, 1-8% of methyl glucose sesquistearate, 1-8% of cetearyl alcohol, 2-6% of polydimethylsiloxane, 1-6% of caprylic/capric triglyceride, 1-6% of stearic acid, 1-4% of shea butter, 0.8-2.5% of glyceryl stearate, 0.1-0.5% of carbomer, 0.1-0.3% of triethanolamine, 0.1-0.3% of phenoxyethanol and the balance of water. The invention takes the traditional Chinese medicine composition and the ultramicro Hetian jade powder as main functional components, has the functions of dredging the muscles and tendons, promoting blood circulation to stop pain, dispelling cold and resolving masses and conditioning the muscles and bones, and can effectively repair bony spur.
Description
Technical Field
The invention relates to a repair cream, in particular to a spur repair cream containing Hetian jade microelements.
Background
Bone spur is the natural aging phenomenon that cartilage is worn and damaged by various reasons and the bone is repaired, hardened and proliferated. The spur belongs to the category of arthralgia syndrome in traditional Chinese medicine, and is also called bone bi-syndrome. The traditional Chinese medicine considers that the disease is related to the causes of trauma, strain, blood stasis blocking collaterals, affection of wind-cold-dampness pathogen, phlegm-dampness internal resistance, liver and kidney deficiency, hyperosteogeny and the like. The middle-aged and the elderly gradually decline in body function, deficiency of qi and blood, malnutrition of channels and collaterals, and malnutrition of tendons and bones. The generation of spur is preceded by the failure of healthy qi to store inside, and then caused by pathogenic wind, cold, dampness, and stasis in the meridians and collaterals, resulting in unsmooth circulation of qi and blood, obstruction of the meridians and collaterals causing pain, and intermingled pathogenic qi. However, the spur is not exclusive to the elderly, and due to the change of working form, many office workers must sit or stand for a long time, and if the posture is incorrect, the spine is easy to degenerate early in age and gently, so that the spur is induced.
At present, most western medicines are treated by operation, so that the medical cost is high and the pain is great, and the traditional Chinese medicine has a plurality of formulas for treating the bony spur, but has the defects of low curative effect, slow response, complex formula medicine and the like. The invention patent CN201310614188.4 discloses a medicament for treating bony spur, which is characterized by comprising the following components in parts by weight: euphorbia kansui: 5-10%, radix angelicae: 5-10%, notopterygium root: 9-18%, pubescent angelica root: 10-20%, Chuanyun: 10-20%, corydalis tuber: 6-12%, garden balsam stem: 6-12%, caulis Spatholobi: 10-20%, spina gleditsiae: 9-18%, fructus toosendan: 7-14%, radix sophorae tonkinensis: 10 to 30 percent. The raw materials of the invention are relatively common, so that the whole medicine has substantial price, does not need to be operated, does not influence normal work and life, and has no pain when in use. However, the components of the invention are relatively complicated and the curative effect is general.
Disclosure of Invention
Based on the above, the invention aims to provide the bone spur repairing cream containing Hetian jade microelements, which takes the traditional Chinese medicine composition and the ultramicro Hetian jade powder as main functional components, has the effects of dredging tendons and vessels, promoting blood circulation to arrest pain, dispelling cold and resolving masses, conditioning muscles and bones, and can effectively repair bone spurs.
The invention adopts the following technical scheme:
the bone spur repairing cream containing the Hetian jade microelements comprises the following components in percentage by mass: 4-20% of a traditional Chinese medicine composition and 1-10% of ultramicro Hetian jade powder; wherein the traditional Chinese medicine composition is prepared from drynaria rhizome, muskmelon seed, passionflower herb and lobster sauce ginger according to the proportion of (1-5): (1-5): (1-5): (1-5) mixing and extracting.
The preparation method of the ultramicro Hetian jade powder comprises the following steps:
(1) cleaning crushed Hetian jade, removing impurities, and drying at low temperature;
(2) adding the removed Hetian jade into a vibration mill to grind into superfine powder with the particle size less than 10 mu m;
(3) and (3) burning the obtained powder at high temperature of 600-800 ℃ for 10min to remove mercury and arsenic in the powder, and cooling to obtain the ultramicro Hetian jade powder.
The preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) weighing rhizoma Drynariae, semen melo, herba Passiflorae Caeruleae, semen Sojae Preparatum and rhizoma Zingiberis recens at a certain proportion, mixing, pulverizing in a pulverizer, and sieving with 100-200 mesh sieve to obtain mixed medicinal powder;
(2) according to the material-liquid ratio of 1: 5-15 adding 65% -85% ethanol into the mixed powder in the step (1), heating to 70 ℃, extracting under reflux for 1-3 times, extracting for 1-3 hours each time, filtering, and combining the filtrates;
(3) and (4) evaporating and concentrating the filtrate obtained in the step (3) to remove ethanol.
The bone spur repairing cream containing the Hetian jade microelements also comprises the following components in percentage by mass:
1-8% of methyl glucose sesquistearate, 1-8% of cetearyl alcohol, 2-6% of polydimethylsiloxane, 1-6% of caprylic/capric triglyceride, 1-6% of stearic acid, 1-4% of shea butter, 0.8-2.5% of glycerol stearate, 0.1-0.5% of carbomer, 0.1-0.3% of triethanolamine, 0.1-0.3% of phenoxyethanol and the balance of water.
The main functional components in the formula of the invention are introduced as follows:
rhizoma drynariae: warm in nature and bitter in taste. It enters liver and kidney meridians. Has effects in promoting wound healing, relieving pain, invigorating kidney, and strengthening bone. Pharmacological experiments show that the naringin has obvious effect of promoting bone injury healing and is one of the effective components of the rhizoma drynariae. The product also has effects in promoting bone absorption of calcium, increasing blood calcium and blood phosphorus levels, and promoting fracture healing. The rhizoma drynariae has certain functions of improving the function of chondrocytes and delaying cell degeneration.
Melon seeds: cold in nature and sweet in taste. It enters lung meridian, stomach meridian and large intestine meridian. Has effects of clearing lung-heat, moistening intestine, removing blood stasis, expelling pus, healing wound and relieving pain. Can be used for treating cough due to lung heat, constipation, pulmonary abscess, intestinal abscess, traumatic injury, and fracture and injury of tendons and bones.
Passionflower herb: warm in nature and bitter in taste. There is no meridian tropism. Has effects of dispelling pathogenic wind, removing dampness, promoting blood circulation, and relieving pain. It can be used for treating common cold, headache, nasal obstruction, watery nasal discharge, rheumatic arthralgia, hernia pain, dysmenorrhea, neuralgia, insomnia, dysentery, and fracture.
Fermented soya bean and ginger: pungent and bitter with warm nature. It enters stomach meridian, spleen meridian and liver meridian. Has effects of dispelling pathogenic wind, removing dampness, warming spleen and stomach, dispelling cold, activating qi-flowing, and promoting blood circulation. Can be used for treating common cold, wind cold, edema, loempe, arthralgia due to wind-cold-dampness, puerperal abdominal pain, blood stasis, dysmenorrhea, and abdominal distention due to qi stagnation and cold.
Hetian jade: one of the four Chinese jade products, Hetian jade is recorded in ancient medical titles such as Shennong's herbal Jing and Ben Cao gang mu: hetian jade has effects of removing heat, moistening heart and lung, nourishing hair, nourishing five internal organs, calming soul, dredging blood vessels, improving eyesight and ear, and there are 106 methods for oral administration and topical application. Hetian jade contains more than 10 trace elements, such as gold, silver, silicon, iron, selenium, magnesium, manganese, etc., and has effects of promoting blood circulation, enhancing metabolism, eliminating skin toxin, resisting radiation, repairing damaged skin cell and enhancing cell activity.
Compared with the prior art, the invention has the following beneficial effects:
(1) the traditional Chinese medicine composition is prepared by reasonably matching rhizoma drynariae, muskmelon seeds, passionflower herb and black bean ginger and scientifically mixing and extracting the components, can generate a synergistic interaction effect among the components, has the effects of dredging tendons and vessels, activating blood circulation to stop pain, dispelling cold and resolving masses and conditioning tendons and bones, and can effectively repair bony spurs.
(2) The invention also adds the ultramicro Hetian jade powder, which can supplement trace elements, promote local blood circulation, enhance metabolism and further repair bony spur.
(3) The product of the invention has the characteristics of mildness, no stimulation and no toxic or side effect, and can effectively repair bony spur.
Detailed Description
The invention is further illustrated by the following examples.
All ingredient names appearing herein are inci (international Nomenclature Cosmetic ingredient), a name specified by international Nomenclature for Cosmetic materials.
Examples 1-5 of the present invention formulations of the spur-repairing cream containing nephrite trace elements are shown in table 1.
TABLE 1
Comparative example 1
The difference from example 1 is that the traditional Chinese medicine composition is not added, and other preparation methods and conditions are the same as example 1.
Comparative example 2
The difference from example 1 is that no ultra fine hetian jade powder was added and the other preparation methods and conditions were the same as example 1.
Comparative example 3
The difference from the example 1 is that the traditional Chinese medicine composition does not contain rhizoma drynariae and melon seeds, and other preparation methods and conditions are the same as the example 1.
Comparative example 4
The difference from the example 1 is that the traditional Chinese medicine composition does not contain passion flower and lobster sauce ginger, and other preparation methods and conditions are the same as the example 1.
Example 6
Irritation test
10 Kunming mice are selected, the weight of the mice is 18-22 g, and the mice can be used for male and female. The bone spur repairing cream containing the Hetian jade microelements prepared in the embodiments 1-5 of the invention is externally applied according to 35 times of the dosage of people, the weight of the bone spur repairing cream is respectively weighed before and after the bone spur repairing cream is applied, and the eating, the activity and the fur condition of the white mouse are observed. After 7 days of continuous observation, no abnormality was found.
Example 7
Efficacy verification
In order to show the treatment effect of the product on the bony spur, through clinical treatment observation of 150 patients, 80 cases of men and 70 cases of women are observed. The patients were randomly divided into 10 groups of 8 men and 7 women, and the products prepared in examples 1 to 5 and comparative examples 1 to 4 of the present invention and commercially available drugs for treating bony spur were used.
Diagnostic criteria: the patients are not cured for a long time. The patients were confirmed in several hospitals.
The observation method comprises the following steps: the clinical symptoms before and after treatment are compared and followed for more than half a year.
The administration method comprises the following steps: the medicine is taken in the morning and at the evening. Two weeks is a course of treatment. After the treatment course is over, the local changes before and after the treatment are compared, and the specific results are shown in Table 2.
And (3) judging the curative effect standard:
and (3) curing: clinical symptoms disappear and the disease does not recur in half a year,
the effect is shown: the clinical symptoms partially disappeared.
And (4) invalidation: clinical symptoms did not progress significantly.
TABLE 2
As can be seen from the data in Table 2, the number of the patients with bony spur cured by the example group is obviously higher than that of the comparative example group and the commercial product group, which shows that the product of the invention can well treat bony spur; the comparison of the data of the embodiment group and the comparative example group can show that the traditional Chinese medicine composition and the ultramicro Hetian jade powder in the formula are main functional components, and the rhizoma drynariae, the muskmelon seed, the passionflower herb and the fermented soya bean ginger in the traditional Chinese medicine composition have a synergistic effect.
The foregoing examples are illustrative of embodiments of the present invention only and are not intended to be limiting in any way; those skilled in the art can make various changes and modifications to the disclosed technology, which are equivalent to those of the embodiments of the present invention, and it is within the scope of the present invention to make various changes and modifications of the invention based on the technical spirit of the present invention.
Claims (5)
1. The bone spur repairing cream containing the Hetian jade microelements is characterized by comprising the following components in percentage by mass: 4-20% of a traditional Chinese medicine composition and 1-10% of ultramicro Hetian jade powder; wherein the traditional Chinese medicine composition is prepared from drynaria rhizome, muskmelon seed, passionflower herb and lobster sauce ginger according to the proportion of (1-5): (1-5): (1-5): (1-5) mixing and extracting.
2. The bone spur repairing cream containing nephrite jade trace elements as claimed in claim 1, wherein the preparation method of the ultramicro nephrite jade powder comprises the following steps:
(1) cleaning crushed Hetian jade, removing impurities, and drying at low temperature;
(2) adding the removed Hetian jade into a vibration mill to grind into superfine powder with the particle size less than 10 mu m;
(3) and (3) burning the obtained powder at high temperature of 600-800 ℃ for 10min to remove mercury and arsenic in the powder, and cooling to obtain the ultramicro Hetian jade powder.
3. The bone spur repairing cream containing Hetian jade microelements as claimed in claim 1, wherein the preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) weighing rhizoma Drynariae, semen melo, herba Passiflorae Caeruleae, semen Sojae Preparatum and rhizoma Zingiberis recens at a certain proportion, mixing, pulverizing in a pulverizer, and sieving with 100-200 mesh sieve to obtain mixed medicinal powder;
(2) according to the material-liquid ratio of 1: 5-15 adding ethanol into the mixed medicinal powder in the step (1), heating to 70 ℃, extracting under reflux for 1-3 times, extracting for 1-3 hours each time, filtering, and combining the filtrates;
(3) and (4) evaporating and concentrating the filtrate obtained in the step (3) to remove ethanol.
4. The bone spur repairing cream containing hothe jade trace elements as claimed in claim 3, wherein the concentration of ethanol in the step (2) is 65% -85%.
5. The bone spur repairing cream containing the Hetian jade trace elements as claimed in claim 1, further comprising the following components in percentage by mass:
1-8% of methyl glucose sesquistearate, 1-8% of cetearyl alcohol, 2-6% of polydimethylsiloxane, 1-6% of caprylic/capric triglyceride, 1-6% of stearic acid, 1-4% of shea butter, 0.8-2.5% of glycerol stearate, 0.1-0.5% of carbomer, 0.1-0.3% of triethanolamine, 0.1-0.3% of phenoxyethanol and the balance of water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010701310.1A CN111904996A (en) | 2020-07-20 | 2020-07-20 | Bone spur repairing cream containing Hetian jade microelements |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010701310.1A CN111904996A (en) | 2020-07-20 | 2020-07-20 | Bone spur repairing cream containing Hetian jade microelements |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111904996A true CN111904996A (en) | 2020-11-10 |
Family
ID=73280498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010701310.1A Pending CN111904996A (en) | 2020-07-20 | 2020-07-20 | Bone spur repairing cream containing Hetian jade microelements |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111904996A (en) |
-
2020
- 2020-07-20 CN CN202010701310.1A patent/CN111904996A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520654B (en) | A kind of Chinese medicine composition being used for the treatment of knee osteoarthritis and preparation method thereof | |
CN112494606A (en) | Traditional Chinese medicine composition for treating arthralgia, myalgia and rheumatic pain and preparation method and application thereof | |
CN105999105A (en) | Traditional Chinese medicine composition for treating bedsores and diabetic ulcers and preparation method thereof | |
CN102580142B (en) | Chinese medicinal liniment for postoperative healing of orthopaedic surgery and preparation method | |
CN103932176B (en) | A health food composition with the function of assisting in lowering blood fat, its preparation method and application | |
CN100374147C (en) | Traditional Chinese medicine preparation for treating mammary gland hyperplasia | |
CN111904996A (en) | Bone spur repairing cream containing Hetian jade microelements | |
CN103919888B (en) | A kind of compound hair oil and preparation method thereof | |
CN106983813B (en) | A pharmaceutical composition for treating lumbago and preparation method thereof | |
CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
CN103816450B (en) | A kind of Chinese medicine for the treatment of rheumatoid arthritis | |
CN110538308A (en) | Traditional Chinese medicine composition for hair growth and preparation method thereof | |
CN104800499B (en) | One kind is used to treat cervical spondylopathy, arthritic traditional Chinese medicine oral liquid and preparation method thereof | |
CN104666806A (en) | Traditional Chinese medicine for treating epidemic meningitis | |
CN114931601B (en) | External traditional Chinese medicine composition for easing pain and preparation method and pharmaceutical application thereof | |
CN115645503B (en) | Pharmaceutical composition and acupoint application ointment for chronic pain diseases | |
CN106074813A (en) | A kind of Chinese medicine fumigation and washing soaking agent treating talalgia and preparation method thereof | |
CN105535817A (en) | A traditional Chinese medicine composition containing argy wormwood leaves and used for treating cervical spondylosis and a preparing method thereof | |
CN105920189A (en) | Traditional Chinese medicine composition for treating talalgia due to liver-kidney deficiency and preparation method thereof | |
CN105998532A (en) | Preparation method for traditional Chinese medicine for treating Qi-stagnancy and blood stasis painful heel and composition of traditional Chinese medicine | |
CN105079319A (en) | Prescription for treating sciatica | |
CN103566052B (en) | A kind of Chinese medicine for the treatment of thyroid tumor | |
CN118680977A (en) | A Chinese medicine composition for treating arthralgia and its preparation method | |
CN117414402A (en) | Traditional Chinese medicine composition for treating lumbago, preparation and preparation method | |
CN103690865B (en) | A kind of spinal surgery postoperative wound nursing powder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201110 |